SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andersson A.F.) "

Sökning: WFRF:(Andersson A.F.)

  • Resultat 1-10 av 24
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Overview of the JET results
  • 2015
  • Ingår i: Nuclear Fusion. - : IOP Publishing. - 0029-5515 .- 1741-4326. ; 55:10
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  • Andersson, A. F., et al. (författare)
  • Comparative analysis of human gut microbiota by barcoded pyrosequencing
  • 2008
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 3:7
  • Tidskriftsartikel (refereegranskat)abstract
    • Humans host complex microbial communities believed to contribute to health maintenance and, when in imbalance, to the development of diseases. Determining the microbial composition in patients and healthy controls may thus provide novel therapeutic targets. For this purpose, high-throughput, cost-effective methods for microbiota characterization are needed. We have employed 454-pyrosequencing of a hyper-variable region of the 16S rRNA gene in combination with sample-specific barcode sequences which enables parallel in-depth analysis of hundreds of samples with limited sample processing. In silico modeling demonstrated that the method correctly describes microbial communities down to phylotypes below the genus level. Here we applied the technique to analyze microbial communities in throat, stomach and fecal samples. Our results demonstrate the applicability of barcoded pyrosequencing as a high-throughput method for comparative microbial ecology.
  •  
3.
  • Andersson, Björn, 1977, et al. (författare)
  • Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children
  • 2009
  • Ingår i: Proteome Science. - : Springer Science and Business Media LLC. - 1477-5956. ; 7
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The broad range in growth observed in response to growth hormone (GH) treatment is mainly caused by individual variations in both GH secretion and GH sensitivity. Individual GH responsiveness can be estimated using evidence-based models that predict the response to GH treatment; however, these models can be improved. High-throughput proteomics techniques can be used to identify proteins that may potentially be used as variables in such models in order to improve their predictive ability. Previously we have reported that proteomic analyses can identify biomarkers that discriminate between short prepubertal children with idiopathic short stature (ISS) who show good or poor growth in response to GH treatment. In this study we used a pharmaco-proteomic approach to identify novel factors that correlate with the growth response to GH treatment in prepubertal children who are short due to GH deficiency or ISS. The study included 128 short prepubertal children receiving GH treatment, of whom 39 were GH-deficient and 89 had ISS. Serum protein expression profiles at study start and after 1 year of GH treatment were analyzed using SELDI-TOF. Cross-validated regression and random permutation analyses were performed to identify significant correlations between protein expression patterns and the 2-year growth response to GH treatment. RESULTS: At start of treatment we identified a combination of seven protein peaks that correlated with the 2-year growth response in the GH-deficient group (R2 = 0.73). After 1 year of treatment, a combination of four peaks in the GH-deficient group (R2 = 0.64), eight peaks in the ISS group R2 = 0.47) and eight peaks in the total study group correlated with the 2-year growth response R2 = 0.38).The peaks identified corresponded to apolipoproteins A-I, A-II, C-I, C-III, transthyretin and serum amyloid A 4, which are all part of the high-density lipoprotein. CONCLUSION: Using a proteomic approach we identified biomarkers related to the lipoprotein profile that could be used to predict growth response to GH treatment in prepubertal children who are short as a result of GH-deficiency or who have ISS.These results support our previous findings that apolipoproteins and transthyretin may have a role in GH sensitivity.
  •  
4.
  •  
5.
  • Collaboration, The PANDA, et al. (författare)
  • Feasibility studies of time-like proton electromagnetic form factors at PANDA at FAIR
  • 2016
  • Ingår i: European Physical Journal A. - : Springer Publishing Company. - 1434-6001 .- 1434-601X. ; 52:10
  • Tidskriftsartikel (refereegranskat)abstract
    • Simulation results for future measurements of electromagnetic proton form factors at P ¯ ANDA (FAIR) within the PandaRoot software framework are reported. The statistical precision with which the proton form factors can be determined is estimated. The signal channel p¯ p→ e+e- is studied on the basis of two different but consistent procedures. The suppression of the main background channel, i.e.p¯ p→ π+π-, is studied. Furthermore, the background versus signal efficiency, statistical and systematical uncertainties on the extracted proton form factors are evaluated using two different procedures. The results are consistent with those of a previous simulation study using an older, simplified framework. However, a slightly better precision is achieved in the PandaRoot study in a large range of momentum transfer, assuming the nominal beam conditions and detector performance.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Grasselli, R. K., et al. (författare)
  • Inhibition of propylene oxidation to acrylic acid by amorphous overlayers on MoV(Nb)TeO based M2 catalysts
  • 2008
  • Ingår i: Catalysis Letters. - : Springer Science and Business Media LLC. - 1011-372X .- 1572-879X. ; 126:3-4, s. 231-240
  • Tidskriftsartikel (refereegranskat)abstract
    • One of the most effective catalysts for the selective oxidation of propane to acrylic acid (AA) and ammoxidation to acrylonitrile (AN) is the MoV(Nb,Ta)(Te,Sb)O system, comprised of two phases, with M1 the major catalyst and M2 the co-catalyst in symbiosis with M1, converting intermediately formed propylene to the respective desired end products. An improvement in either phase should enhance the overall desired yields of a combined M1/M2 conglomerate. The current study concentrates on the M2 phase (variously substituted and/or doped) where depending on composition and preparation technique crystalline materials or crystalline materials with amorphous overlayers are obtained. Crystalline M2 catalysts without amorphous overlayers are vastly superior to those encumbered with overlayers. In a comparative study the former give a maximum AN yield of *45% in propylene ammoxidation, the latter *24%. In the selective oxidation of propylene to acrylic acid, the difference in performance between the two types of catalysts becomes enormous: The crystalline M2 catalyst gives a maximum AA yield of *34% while the Te–molybdate overlayered M2 a meager *3%. Doping of crystalline M2 phase with P significantly enhances AA yields over the base and should be seriously considered in future attempts to improve M1/M2 propane/propylene catalyst systems.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 24

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy